Patient education on prostate cancer screening and involvement in decision making

Annals of Family Medicine

Volumn 5, Issue 2, 2007, Pages 112-119

  Krist, Alex H ^a   Woolf, Steven H ^a   Johnson, Robert E ^a   Kerns, J William ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Decision making; Guideline adherence statistics numerical data; Information management; Mass screening methods; Patient education methods; Prevention cancer; Prostatespecific antigen blood; Prostatic neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOCTOR PATIENT RELATION; HEALTH EDUCATION; HEALTH PROMOTION; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT ATTITUDE; PATIENT EDUCATION; PATIENT PARTICIPATION; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL;

AGED; ATTITUDE OF HEALTH PERSONNEL; DECISION MAKING; DECISION SUPPORT TECHNIQUES; HUMANS; INTERNAL-EXTERNAL CONTROL; INTERNET; MALE; MASS SCREENING; MIDDLE AGED; PAPER; PATIENT EDUCATION; PATIENT PARTICIPATION; PROSTATIC NEOPLASMS;

EID: 34047155525     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.623     Document Type: Article

References (39)

1. Stamey TA, Caldwell M, McNeal JE, et al. The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? J Urol. 2004;172(4 Pt 1):1297-1301.
2. Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter. N Engl J Med. 2004;350(22):2239-2246.
3. Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA). Oncology (Williston Park). 2000;14(2):267-272, 277-268, 280 passim.
4. Summaries for patients. Screening for prostate cancer: a recommendation from the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137(11):I48.
5. Smith RA, Cokkinides V, von Eschenbach AC, et al. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin. 2002;52(1):8-22.
6. Sheridan SL, Harris RP, Woolf SH. Shared decision making about screening and chemoprevention. A suggested approach from the U.S. Preventive Services Task Force. Am J Prev Med. 2004;26(1):56-66.
7. Hurtado MP, Swift EK, Corrigan JM, eds. Envisioning the National Healthcare Quality Report. Washington DC: Institute of Medicine; 2000. Available at: http://www.nap.edu/books/030907343X/html/.Accessed: 25 January 2005.
8. Yarnall KS, Pollak KI, Ostbye T, Krause KM, Michener JL. Primary care: is there enough time for prevention? Am J Public Health. 2003;93(4):635-641.
9. Merenstein D. A piece of my mind. Winners and losers. JAMA. 2004;291(1):15-16.
10. Schwartz LM, Woloshin S, Fowler FJ Jr, Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291(1):71-78.
11. Woolf SH, Krist A. The liability of giving patients a choice: shared decision making and prostate cancer. Am Fam Physician. 2005;71(10):1871-1872.
12. Davison BJ, Kirk P, Degner LF, Hassard TH. Information and patient participation in screening for prostate cancer. Patient Educ Couns. 1999;37(3):255-263.
13. Volk RJ, Cass AR, Spann SJ. A randomized controlled trial of shared decision making for prostate cancer screening. Arch Fam Med. 1999;8(4):333-340.
14. Frosch DL, Kaplan RM, Felitti V. The evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test. J Gen Intern Med. 2001;16(6):391-398.
15. Schapira MM, VanRuiswyk J. The effect of an illustrated pamphlet decision-aid on the use of prostate cancer screening tests. J Fam Pract. 2000;49(5):418-424.
16. Wolf AM, Nasser JF, Schorling JB. The impact of informed consent on patient interest in prostate-specific antigen screening. Arch Intern Med. 1996;156(12):1333-1336.
17. Wantland DJ, Portillo CJ, Holzemer WL, Slaughter R, McGhee EM. The effectiveness of Web-based vs. non-Web-based interventions: a meta-analysis of behavioral change outcomes. J Med Internet Res. 2004;6(4):e40.
18. Baker L, Wagner TH, Singer S, Bundorf MK. Use of the Internet and e-mail for health care information: results from a national survey. JAMA. 2003;289(18):2400-2406.
19. American Academy of Family Physicians. Should you get a PSA test? A patient-doctor decision. Available at: http://www.aafp.org/online/etc/medialib/ aafp_org/documents/clinical/patient_ed/prostatescreening_ patient.Par.0001.File. tmp/prostate_patient_tool.pdf. Accessed: 25 January 2005.
20. Mayo Clinic. Prostate cancer screening: know your options. Available at: http://www.mayoclinic.com/invoke.cfm?objectid=E3657711-F837-4DE5- A8BC93BC4D0EE475. Accessed: 25 January 2005.
21. Centers for Disease Control and Prevention. Prostate cancer screening: a decision guide. Available at: http://www.cdc.gov/cancer/prostate/publications/ decisionguide/. Accessed: 25 January 2005.
22. Frosch DL, Kaplan RM, Felitti VJ. A randomized controlled trial comparing Internet and video to facilitate patient education for men considering the prostate specific antigen test. J Gen Intern Med. 2003;18(10):781-787.
23. Woolf SH, Krist AH, Johnson RE, Stenborg PS. Unwanted control: how patients in the primary care setting decide about screening for prostate cancer. Patient Educ Couns. 2005;56(1):116-124.
24. Krist A, McCormally T. What patients want from their doctor's website, poster abstract. Fam Med. 2001;33:552.
25. Department of Family Medicine, Virginia Commonwealth University. Should you get a PSA test? A patient-doctor decision. Available at: http://www.acorn.fap.vcu.edu/psa/. Accessed: 18 March 2005.
26. Degner LF, Sloan JA. Decision making during serious illness: what role do patients really want to play? J Clin Epidemiol. 1992;45(9):941-950.
27. Degner LF, Sloan JA, Venkatesh P. The Control Preferences Scale. Can J Nurs Res. 1997;29(3)21-43.
28. O'Dell KJ, Volk RJ, Cass AR, Spann SJ. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions? J Fam Pract. 1999;48(9):682-688.
29. O'Connor A. Decisional Conflict Scale. 4th ed. Ottawa, Ontario: University of Ottawa; 1999.
30. Elwyn G, Edwards A, Mowle S, et al. Measuring the involvement of patients in shared decision-making: a systematic review of instruments. Patient Educ Couns. 2001;43(1):5-22.
31. SAS. Version 9.1.3. Copyright 2002-2003. Cary, NC: SAS Institute Inc.
32. O'Connor AM, Legare F, Stacey D. Risk communication in practice: the contribution of decision aids. BMJ. 2003;327(7417):736-740.
33. O'Connor AM, Stacey D, Entwistle V, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2003;(2):CD001431.
34. McNutt RA. Shared medical decision making: problems, process, progress. JAMA. 2004;292(20):2516-2518.
35. Elwyn G, Edwards A, Wensing M, et al. Shared decision making: developing the OPTION scale for measuring patient involvement. Qual Saf Health Care. 2003;12(2):93-99.
36. Edwards A, Elwyn G, Hood K, et al. The development of COMRADE - a patient-based outcome measure to evaluate the effectiveness of risk communication and treatment decision making in consultations. Patient Educ Couns. 2003;50(3):311-322.
37. Pew Internet and American Life Project. Internet usage over time. Available at: http://www.pewinternet.org. Accessed: 18 March 2005.
38. Krist A, Woolf S, Johnson R. How physicians approach prostate cancer screening before and after losing a lawsuit. Ann Fam Med. 2007;5(2)120-125.
39. Flood AB, Wennberg JE, Nease RF, Jr., et al. The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team. J Gen Intern Med. 1996;11(6):342-349.